Safety and efficacy of the tracheobronchial bonastent

• Verfasst von: Holden, Van Kim [VerfasserIn]
• Verfasst von: Ospina-Delgado, Daniel [VerfasserIn]
• Verfasst von: Chee, Alex [VerfasserIn]
• Verfasst von: Parikh, Mihir S. [VerfasserIn]
• Verfasst von: Carreiro, Megan M. [VerfasserIn]
• Verfasst von: Alape Moya, Daniel [VerfasserIn]
• Verfasst von: Fernandez-Bussy, Sebastian [VerfasserIn]
• Verfasst von: Herth, Felix [VerfasserIn]
• Verfasst von: Majid, Adnan [VerfasserIn]
• Titel: Safety and efficacy of the tracheobronchial bonastent
• Titelzusatz: a single-center case series
• Verf.angabe: Van Kim Holden, Daniel Ospina-Delgado, Alex Chee, Mihir S. Parikh, Megan M. Carreiro, Daniel Alape Moya, Sebastian Fernandez-Bussy, Felix J. F. Herth, Adnan Majid
• E-Jahr: 2020
• Jahr: April 2020
• Umfang: 8 S.
• Fussnoten: Gesehen am 14.10.2020
• Titel Quelle: Enthalten in: Respiration
• Ort Quelle: Basel : Karger, 1944
• Jahr Quelle: 2020
• Band/Heft Quelle: 99(2020), 4, Seite 353-359
• ISSN Quelle: 1423-0356
• DOI: doi:10.1159/000506815
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 173555135X

Abstract

<b><i>Background:</i></b> Tracheobronchial stents are widely used devices in interventional pulmonology; however, the current literature on the effectiveness and complication rates of the different types of stents is limited. <b><i>Objective:</i></b> We report the largest case series of airway Bonastent placement and describe the efficacy and early (&#x3c;30 days) and late (≥30 days) complication rates. <b><i>Methods:</i></b> We performed a retrospective review of our prospectively collected database of patients who underwent therapeutic bronchoscopy with stent placement. All adult patients who had a tracheal/bronchial Bona­stent placed between July 1, 2017, and July 30, 2019, for any indication at our institution were included. The efficacy as well as intraoperative and short- and long-term complications of Bonastent placement were evaluated. <b><i>Results:</i></b> Sixty Bonastents were placed in 50 patients. The etiology was malignant in 90% of the cases, while 2 patients had a tracheoesophageal fistula. All procedures were performed via rigid bronchoscopy. The most common location for stent placement was the bronchus intermedius, followed by the trachea, in 32 and 30% of the cases, respectively. Seventy percent of the patients (35/50) had improvement of respiratory symptoms within 30 days. Twenty-eight stents (48%) were removed at a mean of 74 days. Seventeen patients (34%) died within 30 days of stent placement. The overall complication rate was 54% (27/50 patients) at a mean follow-up of 111 days. The stent-related complication rate was 23.3% (14/60 cases) within &#x3c;30 days and 53% (18/34 cases) at ≥30 days. <b><i>Conclusions:</i></b> The tracheobronchial Bonastent is effective for the treatment of patients with central airway obstruction and tracheoesophageal fistulae with an acceptable safety profile.